Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool

Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Unnikrishnan, A. G., Baruah, Manash, Kawatra, Pallavi, Ved, Jignesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628551/
https://www.ncbi.nlm.nih.gov/pubmed/28989889
http://dx.doi.org/10.4103/ijem.IJEM_184_17
_version_ 1783268906518970368
author Kalra, Sanjay
Unnikrishnan, A. G.
Baruah, Manash
Kawatra, Pallavi
Ved, Jignesh
author_facet Kalra, Sanjay
Unnikrishnan, A. G.
Baruah, Manash
Kawatra, Pallavi
Ved, Jignesh
author_sort Kalra, Sanjay
collection PubMed
description Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize the pharmaco-ergonomic considerations for these agents, in the form of an SGLT2-i qualification tool, based on a clinical score. This tool may serve as a simple and inexpensive practical guide, to optimize the risk-benefit considerations for SGLT2-i agents.
format Online
Article
Text
id pubmed-5628551
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56285512017-10-06 Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool Kalra, Sanjay Unnikrishnan, A. G. Baruah, Manash Kawatra, Pallavi Ved, Jignesh Indian J Endocrinol Metab Review Article Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize the pharmaco-ergonomic considerations for these agents, in the form of an SGLT2-i qualification tool, based on a clinical score. This tool may serve as a simple and inexpensive practical guide, to optimize the risk-benefit considerations for SGLT2-i agents. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5628551/ /pubmed/28989889 http://dx.doi.org/10.4103/ijem.IJEM_184_17 Text en Copyright: © 2017 Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Kalra, Sanjay
Unnikrishnan, A. G.
Baruah, Manash
Kawatra, Pallavi
Ved, Jignesh
Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title_full Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title_fullStr Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title_full_unstemmed Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title_short Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
title_sort sodium-glucose cotransporter 2 inhibitor use: a pharmaco-ergonomic qualification tool
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628551/
https://www.ncbi.nlm.nih.gov/pubmed/28989889
http://dx.doi.org/10.4103/ijem.IJEM_184_17
work_keys_str_mv AT kalrasanjay sodiumglucosecotransporter2inhibitoruseapharmacoergonomicqualificationtool
AT unnikrishnanag sodiumglucosecotransporter2inhibitoruseapharmacoergonomicqualificationtool
AT baruahmanash sodiumglucosecotransporter2inhibitoruseapharmacoergonomicqualificationtool
AT kawatrapallavi sodiumglucosecotransporter2inhibitoruseapharmacoergonomicqualificationtool
AT vedjignesh sodiumglucosecotransporter2inhibitoruseapharmacoergonomicqualificationtool

Ejemplares similares